A Path to Prosperity New Directions for African Livestock
GALVmed Impetus Strategy Paper
GALVmed Impetus Strategy Paper
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Annex 3<br />
Overview of GALVmed<br />
GALVmed is a registered charity that began<br />
operations in November 2005. Since its inception<br />
GALVmed has supported the Millennium<br />
Development Goals by playing a major role in<br />
poverty reduction and livelihood enhancement<br />
through lives<strong>to</strong>ck interventions. The charity’s<br />
mission is <strong>to</strong> protect lives<strong>to</strong>ck and save human<br />
lives by:<br />
> Developing, registering and launching several<br />
vaccines, pharmaceutical and diagnostic<br />
products over the next 10 years<br />
> Partnering with organisations in developing<br />
countries <strong>to</strong> ensure sustainable research,<br />
production and delivery of new products <strong>to</strong> poor<br />
lives<strong>to</strong>ck keepers<br />
> In<strong>for</strong>ming stakeholders on the links between<br />
lives<strong>to</strong>ck and poverty and the role of lives<strong>to</strong>ck<br />
health in achieving the Millennium Development<br />
Goal of eradicating extreme poverty and hunger<br />
> Facilitating dialogue and collaboration in<br />
research ef<strong>for</strong>ts <strong>for</strong> new lives<strong>to</strong>ck vaccines,<br />
medicines and diagnostic systems<br />
GALVmed focuses its ef<strong>for</strong>ts on sub-Saharan <strong>African</strong><br />
and Southern Asian countries afflicted by both<br />
extreme poverty and animal diseases.<br />
GALVmed prides itself on engaging with<br />
stakeholders through core values of integrity,<br />
pro-poor empathy, focus, professionalism,<br />
competency, transparency, commitment and<br />
progressiveness. Since its launch, GALVmed has<br />
grown considerably. The organisation receives<br />
financial backing from the Bill and Melinda Gates<br />
Foundation, the UK’s Department <strong>for</strong> International<br />
Development (DFID) along with specific project<br />
funding from numerous other sources. GALVmed<br />
has partnerships with the pharmaceutical industry,<br />
non-governmental organisations (NGOs),<br />
government organisations and international<br />
agencies and foundations. These partnerships<br />
are vital <strong>to</strong> GALVmed’s existence and the success<br />
of its mission. GALVmed strives <strong>to</strong> ensure that its<br />
decisions are driven by regular dialogue with<br />
community stakeholders.<br />
GALVmed's work is guided by a Board of Direc<strong>to</strong>rs<br />
and observers <strong>to</strong> the board. The board members<br />
reflect a wide range of nationalities and expertise<br />
from the private and public sec<strong>to</strong>rs, along with<br />
research and civil society communities. The current<br />
list of direc<strong>to</strong>rs and observers can be found on<br />
GALVmed's web site 15 . The Board has four<br />
sub-committees: policy and external affairs; finance<br />
/audit; technical; and global access. GALVmed is<br />
further supported by external advisers: an Expert<br />
Scientific Advisory Committee reviews all GALVmed<br />
research plans and a unique Global Access Advisory<br />
Committee, that includes internationally-renowned<br />
experts from several countries on regulation, quality<br />
control, manufacturing, government, distribution,<br />
development, policy, sociology and other related<br />
areas, provides advice <strong>to</strong> GALVmed on all nonscientific<br />
aspects of its work. This includes, <strong>for</strong><br />
example, the development of socio-economic<br />
impact <strong>to</strong>ols <strong>for</strong> the lives<strong>to</strong>ck sec<strong>to</strong>r, strategic<br />
partnerships, production, commercialisation and<br />
sustained delivery of new products, advocacy,<br />
farmer engagement and communications.<br />
GALVmed has a number of qualities that makes it an<br />
effective organisation in terms of impacting the lives<br />
and livelihoods of poor lives<strong>to</strong>ck farmers in Africa<br />
and South Asia.<br />
These strengths include the following:<br />
> GALVmed is relatively new and relatively creative<br />
in its approach. This has helped GALVmed<br />
engage with a number of persistent problems<br />
in the animal health and development world and<br />
<strong>for</strong>mulate solutions.<br />
> Galvmed has a very business-orientated<br />
approach. This reflects GALVmed's private<br />
sec<strong>to</strong>r links and staff experience. GALVmed is<br />
careful about what it invests in. When<br />
investments are made they are closely<br />
moni<strong>to</strong>red against a business plan that includes<br />
miles<strong>to</strong>nes and outputs against agreed<br />
timelines. This allows GALVmed <strong>to</strong> alter course<br />
rapidly <strong>to</strong> invest in success and pull out if results<br />
are not possible. GALVmed is lucky <strong>to</strong> have<br />
donors that understand and support this flexible<br />
and output-orientated approach.<br />
15 http://www.galvmed.org/about-galvmed/leadership<br />
The Impetus Strategy Paper I Page 61